HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus.

Abstract
Olfactory bulbectomy (OBX) in mice elicits impaired memory and cognitive functions. Here, we found that chronic oral administration of spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) (0.1-1 mg/kg/day), a novel cognitive enhancer, significantly improved memory deficits as assessed by Y-maze and novel object recognition tasks in OBX mice. Immunostaining of cholinergic neurons in the medial septum by using an anti-choline acetyltransferase antibody indicated that chronic ZSET1446 treatment did not rescue cholinergic neurons. However, chronic treatment significantly restored OBX-induced decreases both in calcium/calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC) phosphorylation without improving decreased extracellular signal-regulated kinase phosphorylation in the hippocampal CA1 region. Consistent with enhanced CaMKII and PKC phosphorylation, ZSET1446 treatment improved glutamate receptor 1 (Ser-831) phosphorylation in the hippocampal CA1 region. ZSET1446 treatment also significantly rescued impaired long-term potentiation (LTP) in the hippocampal CA1 region of OBX mice. Taken together, the cognition-enhancing effect of ZSET1446 is probably mediated in part by stimulation of CaMKII and PKC activities, which in turn rescue impaired hippocampal LTP in OBX mice.
AuthorsFeng Han, Norifumi Shioda, Shigeki Moriguchi, Yui Yamamoto, Alisa Y Ali Raie, Yoshimasa Yamaguchi, Masataka Hino, Kohji Fukunaga
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 326 Issue 1 Pg. 127-34 (Jul 2008) ISSN: 1521-0103 [Electronic] United States
PMID18388258 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Indans
  • Spiro Compounds
  • spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
Topics
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 (metabolism)
  • Enzyme Activation (drug effects, physiology)
  • Hippocampus (drug effects, enzymology)
  • Indans (pharmacology, therapeutic use)
  • Male
  • Memory Disorders (drug therapy, enzymology)
  • Mice
  • Olfactory Bulb (enzymology, surgery)
  • Protein Kinase C (metabolism)
  • Spiro Compounds (pharmacology, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: